Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1980 Feb;27(2):620–627. doi: 10.1128/iai.27.2.620-627.1980

Investigation of the component of Propionibacterium acnes (Corynebacterium parvum) responsible for macrophage activation.

G E Buck, M T Kelly
PMCID: PMC550809  PMID: 7380542

Abstract

Mouse peritoneal macrophages, activated with Propionibacterium acnes (Corynebacterium parvum) in vivo, exhibited altered morphological characteristics, increased acid phosphatase activity, and release of [EH]thymidine-labeled DNA from tumor cells in vitro. Comparison with macrophages from mice injected with a control organism, P. jensenii, showed that the morphological changes, but not acid phosphatase, correlated with the development of tumoricidal activity. Investigation of the microbial component responsible for this activity indicated it was heat stable and refractory to extraction by methanol-chloroform, dilute acid, butanol, or a serial combination of extraction procedures. When the cells were disrupted by mechanical breakage, no activity could be found in the cell wall, soluble cytoplasm, or particulate cytoplasm. These results suggest that intact organisms are required for macrophage activation, and they may resolve conflicting reports on the nature of the immunostimulating activity of P. acnes.

Full text

PDF
620

Images in this article

623Fig. 1
on p.623

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adlam C., Broughton E. S., Scott M. T. Enhanced resistance of mice to infection with bacteria following pre-treatment with Corynebacterium parvum. Nat New Biol. 1972 Feb 16;235(59):219–220. doi: 10.1038/newbio235219a0. [DOI] [PubMed] [Google Scholar]
  2. Adlam C., Scott M. T. Lympho-reticular stimulatory properties of Corynebacterium parvum and related bacteria. J Med Microbiol. 1973 Aug;6(3):261–274. doi: 10.1099/00222615-6-3-261. [DOI] [PubMed] [Google Scholar]
  3. BLACK P. H., ROWE W. P. SV-40 INDUCED PROLIFERATION OF TISSUE CULTURE CELLS OF RABBIT, MOUSE, AND PORCINE ORIGIN. Proc Soc Exp Biol Med. 1963 Dec;114:721–727. doi: 10.3181/00379727-114-28780. [DOI] [PubMed] [Google Scholar]
  4. BLIGH E. G., DYER W. J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959 Aug;37(8):911–917. doi: 10.1139/o59-099. [DOI] [PubMed] [Google Scholar]
  5. Basić I., Milas L., Grdina D. J., Withers H. R. In vitro destruction of tumor cells by macrophages from mice treated with Corynebacterium granulosum. J Natl Cancer Inst. 1975 Sep;55(3):589–596. doi: 10.1093/jnci/55.3.589. [DOI] [PubMed] [Google Scholar]
  6. Bomford R., Christie G. H. Mechanisms of macrophage activation by corynebacterium parvum. II. In vivo experiments. Cell Immunol. 1975 May;17(1):150–155. doi: 10.1016/s0008-8749(75)80015-3. [DOI] [PubMed] [Google Scholar]
  7. Brener Z., Cardoso J. E. Nonspecific resistance against Trypanosoma cruzi enhanced by Corynebacterium parvum. J Parasitol. 1976 Aug;62(4):645–646. [PubMed] [Google Scholar]
  8. Castro J. E. The effect of Corynebacterium parvum on the structure and function of the lymphoid system in mice. Eur J Cancer. 1974 Feb;10(2):115–120. doi: 10.1016/0014-2964(74)90062-0. [DOI] [PubMed] [Google Scholar]
  9. Clark I. A., Cox F. E., Allison A. C. Protection of mice against Babesia spp. and Plasmodium spp. with killed Corynebacterium parvum. Parasitology. 1977 Feb;74(1):9–18. doi: 10.1017/s003118200004748x. [DOI] [PubMed] [Google Scholar]
  10. Collins F. M., Scott M. T. Effect of Corynebacterium parvum treatment on the growth of Salmonella enteritidis in mice. Infect Immun. 1974 May;9(5):863–869. doi: 10.1128/iai.9.5.863-869.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cummins C. S., Linn D. M. Reticulostimulating properties of killed vaccines of anaerobic coryneforms and other organisms. J Natl Cancer Inst. 1977 Dec;59(6):1697–1708. doi: 10.1093/jnci/59.6.1697. [DOI] [PubMed] [Google Scholar]
  12. Fauve R. M., Hevin B. Immunostimulation with bacterial phospholipid extracts. Proc Natl Acad Sci U S A. 1974 Feb;71(2):573–577. doi: 10.1073/pnas.71.2.573. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fisher B., Wolmark N. Correlation of antitumor chemoimmunotherapy with bone marrow macrophage precursor cell stimulation and macrophage cytotoxicity. Cancer Res. 1976 Jul;36(7 Pt 1):2241–2247. [PubMed] [Google Scholar]
  14. Ghaffar A., Cullen R. T., Dunbar N., Woodruff M. F. Anti-tumour effect in vitro of lymphocytes and macrophages from mice treated with Corynebacterium parvum. Br J Cancer. 1974 Mar;29(3):199–205. doi: 10.1038/bjc.1974.59. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. HALPERN B. N., PREVOT A. R., BIOZZI G., STIFFEL C., MOUTON D., MORARD J. C., BOUTHILLIER Y., DECREUSEFOND C. STIMULATION DE L'ACTIVIT'E PHAGOCYTAIRE DU SYST'EME R'ETICULOENDOTH'ELIAL PROVOQU'EE PAR CORYNEBACTERIUM PARVUM. J Reticuloendothel Soc. 1964 Jan;1:77–96. [PubMed] [Google Scholar]
  16. Howard J. G., Christie G. H., Scott M. T. Biological effects of Corynebacterium parvum. IV. Adjuvant and inhibitory activities on B lymphocytes. Cell Immunol. 1973 May;7(2):290–301. doi: 10.1016/0008-8749(73)90251-7. [DOI] [PubMed] [Google Scholar]
  17. Kaplan A. M., Bear H. D., Kirk L., Cummins C., Mohanakumar T. Relationship of expression of A cell-surface antigen on activated murine macrophages to tumor cell cytotoxicity. J Immunol. 1978 Jun;120(6):2080–2085. [PubMed] [Google Scholar]
  18. Kirchner H., Holden H. T., Herberman Splenic suppressor macrophages induced in mice by injection of Corynebacterium parvum. J Immunol. 1975 Nov;115(5):1212–1216. [PubMed] [Google Scholar]
  19. Krahenbuhl J. L., Lambert L. H., Jr, Remington J. S. Effects of Corynebacterium parvum treatment and Toxoplasma gondii infection on macrophage-mediated cytostasis of tumour target cells. Immunology. 1976 Dec;31(6):837–846. [PMC free article] [PubMed] [Google Scholar]
  20. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  21. McBride W. H., Dawes J., Tuach S. Antitumor activity of Corynebacterium parvum extracts. J Natl Cancer Inst. 1976 Feb;56(2):437–439. [PubMed] [Google Scholar]
  22. Migliore-Samour D., Korontzis M., Jollès P. Hydrosoluble immunopotentiating substances extraced from Corynebacterium parvum. Immunol Commun. 1974;3(6):593–603. doi: 10.3109/08820137409061137. [DOI] [PubMed] [Google Scholar]
  23. Millman I., Scott A. W., Halbherr T. Antitumor activity of Propionibacterium acnes (Corynebacterium parvum) and isolated cytoplasmic fractions. Cancer Res. 1977 Nov;37(11):4150–4155. [PubMed] [Google Scholar]
  24. Morrison D. C., Leive L. Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. J Biol Chem. 1975 Apr 25;250(8):2911–2919. [PubMed] [Google Scholar]
  25. O'Neill G. J., Henderson D. C., White R. G. The role of anaerobic coryneforms on specific and non-specific immunological reactions. I. Effect on particle clearance and humoral and cell-mediated immunological responses. Immunology. 1973 Jun;24(6):977–995. [PMC free article] [PubMed] [Google Scholar]
  26. Oettgen H. F., Pinsky C. M., Delmonte L. Treatment of cancer with immunomodulators. Med Clin North Am. 1976 May;60(3):511–537. doi: 10.1016/s0025-7125(16)31895-8. [DOI] [PubMed] [Google Scholar]
  27. Olivotto M., Bomford R. In vitro inhibition of tumour cell growth and DNA synthesis by peritoneal and lung macrophages from mice injected with Corynebacterium parvum. Int J Cancer. 1974 Apr 15;13(4):478–488. doi: 10.1002/ijc.2910130406. [DOI] [PubMed] [Google Scholar]
  28. Prévot A. R., Nguyen-Dang T., Thouvenot H. Influence des parois cellulaires du Corynebacterium parvum (souche 936 B) sur le système réticulo-endothélial de la souris. C R Acad Sci Hebd Seances Acad Sci D. 1968 Sep 16;267(12):1061–1062. [PubMed] [Google Scholar]
  29. Riveros-Moreno V., Bomford R., Scott M. T. Antitumor activity of purified cell walls from Corynebacterium parvum. J Natl Cancer Inst. 1978 Mar;60(3):653–658. doi: 10.1093/jnci/60.3.653. [DOI] [PubMed] [Google Scholar]
  30. Scott M. T. Biological effects of the adjuvant Corynebacterium parvum. I. Inhibition of PHA, mixed lymphocyte and GVH reactivity. Cell Immunol. 1972 Nov;5(3):459–468. doi: 10.1016/0008-8749(72)90072-x. [DOI] [PubMed] [Google Scholar]
  31. Scott M. T. Depression of delayed-type hypersensitivity by Corynebacterium parvum: mandatory role of the spleen. Cell Immunol. 1974 Aug;13(2):251–263. doi: 10.1016/0008-8749(74)90243-3. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES